NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Leading Pharma

Leading Pharma

Private
Fairfield, New JerseyHealthcare & Life Scienceshttps://leadingpharma.com/

Last Round

Growth Equity

Dec 28, 2017

Total Funding Raised

$40M

Company Overview

Leading Pharma is a pharmaceutical company that develops, manufactures, and distributes generic pharmaceutical products across a wide range of therapeutic areas.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Compliance, Quality Management

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

generic pharmaceuticalsgeneric drugscontract manufacturingoral solid doseauthorized genericspharmaceutical manufacturingabbreviated new drug applicationANDAnew drug applicationNDApharmaceutical supply chaincGMP compliancedrug developmentwhite label pharmapharma CDMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leading Pharma Comps

Public and private peers based on sector, stage, and business model.

Leading Pharma comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Leading Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityDec 28, 2017
M&ADec 31, 2014

Key People

Founding team and executive leadership

Ron Gold

Chief Executive Officer

Executive Team

Mark Viegas

Chief Financial Officer

Executive Team

Leading Pharma Investors

Notable investors and investment history

Leading Pharma investors
InvestorRounds
Signet Healthcare PartnersGrowth Equity
Cane Investment PartnersGrowth Equity
Crestline InvestorsGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2026

    9,384 bottles of Furosemide tablets recalled nationwide due to quality deviation.

Leading Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Leading Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leading Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersFairfield, New Jersey
Employee Range105
Year Founded2014
Last FundingDec 28, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.